New Triple-Threat attack on advanced kidney cancer begins human testing
Disease control
Recruiting now
This study is testing a new combination of three drugs to see if they can safely control advanced kidney cancer that has spread. The trial will enroll about 25 adults with specific types of advanced kidney cancer who have not yet received treatment for their metastatic disease. R…
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC